Abstract
Pediatric HSCT recipients are at high risk for CMV reactivation due to their immature immune system and therapy following transplantation. Reconstitution of CMV-specific T-cell immunity is associated with control and protection against CMV. The clinical utility of monitoring CMV-specific CMI to predict CMV viremia in pediatric HSCT patients using the Quantiferon-CMV (QIAGEN® ) test was investigated prospectively. Thirty-seven pediatric allogeneic HSCT recipients were enrolled from 3/2010-6/2012. CMV viremia was detected via weekly real-time PCR. The Quantiferon-CMV test was conducted pretransplant, early after transplantation, 30, 90, 180, 270, and 360 days post-transplantation. The incidence of CMV viremia was 51% (19/37) with half of the episodes within ≤30 days post-transplant. Fifteen patients showed CMV-specific immunity (average of 82 days). The cumulative incidence of CMV reactivation in patients who developed CMV-specific immunity was lower than those who did not (15% vs 53%; P = .023). The ROC statistical analysis showed that the AUC was 0.725 in predicting viremia, for Quantiferon-CMV test. In this cohort, the Quantiferon-CMV assay was a valuable method for identifying pediatric HSCT patients at high risk for CMV vire...Continue Reading
References
Mar 27, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Per LjungmanCarlos Paya
May 8, 2002·Paediatric Drugs·Javier BuenoMichael Green
Jul 5, 2003·Blood·Morgan HakkiMichael Boeckh
Jun 3, 2004·Human Immunology·Holger Hebart, Hermann Einsele
Jan 18, 2006·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Per Ljungman
Apr 15, 2006·Blood·Daniele LilleriFranco Locatelli
Sep 25, 2008·Bone Marrow Transplantation·P Ljungman
Nov 27, 2008·Pediatric Transplantation·Hoi Soo YoonHo Joon Im
Dec 23, 2008·Immunity·Charles D Surh, Jonathan Sprent
Jan 13, 2009·Clinical Microbiology Reviews·Tania Crough, Rajiv Khanna
May 9, 2009·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·L Danziger-Isakov, P S Heeger
May 9, 2009·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·D KumarA Humar
Mar 11, 2010·Blood·Ruth Seggewiss, Hermann Einsele
Mar 13, 2010·Transplantation·Camille N KottonUNKNOWN Transplantation Society International CMV Consensus Group
Nov 26, 2010·Transplantation Proceedings·A LochmanovaM Grundmann
Dec 8, 2010·British Journal of Haematology·Cécile RénardGérard Michel
Dec 22, 2010·Expert Review of Molecular Diagnostics·Stefano Giulieri, Oriol Manuel
Dec 20, 2011·Transplantation·Luiz F LisboaAtul Humar
Feb 9, 2012·Transplantation·Davide AbateGiorgio Palù
May 17, 2013·Journal of Clinical Microbiology·Davide AbateGiorgio Palù
Oct 23, 2013·PloS One·Siok-Keen TeyRajiv Khanna
Feb 23, 2017·Annals of Laboratory Medicine·Sae Mi LeeEun Suk Kang
Citations
Jul 17, 2019·Clinical Transplantation·Corrado GirmeniaPaolo Grossi
Mar 24, 2020·Blood·Hermann EinseleMichael Boeckh
Aug 20, 2019·Expert Review of Hematology·Enrico MaffiniBenedetto Bruno
Feb 6, 2021·PloS One·Euri SeoJina Lee
Feb 9, 2021·Frontiers in Immunology·Claudio AnnaloroFrancesco Onida
Oct 30, 2020·Clinical Microbiology Reviews·Ajit P LimayeMichael Boeckh
Mar 28, 2021·Scandinavian Journal of Immunology·Lars Klingen GjaerdeHenrik Sengeløv
Jul 7, 2020·La Revue de médecine interne·M BoccardF Ader